Trial Outcomes & Findings for Chronic Gastrointestinal Sequelae of an Acute Outbreak of Bacterial Gastroenteritis in Walkerton Ontario (NCT NCT00235326)
NCT ID: NCT00235326
Last Updated: 2009-04-22
Results Overview
Recruitment status
COMPLETED
Target enrollment
4561 participants
Primary outcome timeframe
8 years
Results posted on
2009-04-22
Participant Flow
Residents of Walkerton in may 2000
Age less than 16, non-residents of walkerton, premorbid Inflammatory Bowel disease(IBD) /Irritable bowel syndrome(IBS)
Participant milestones
| Measure |
Unexposed to Gastroenteritis
|
Exposed to Gastroenteritis
|
|---|---|---|
|
Overall Study
STARTED
|
1575
|
2986
|
|
Overall Study
COMPLETED
|
829
|
1586
|
|
Overall Study
NOT COMPLETED
|
746
|
1400
|
Reasons for withdrawal
| Measure |
Unexposed to Gastroenteritis
|
Exposed to Gastroenteritis
|
|---|---|---|
|
Overall Study
Lost to Follow-up
|
746
|
1400
|
Baseline Characteristics
Chronic Gastrointestinal Sequelae of an Acute Outbreak of Bacterial Gastroenteritis in Walkerton Ontario
Baseline characteristics by cohort
| Measure |
Unexposed to Gastroenteritis
n=1575 Participants
|
Exposed to Gastroenteritis
n=2986 Participants
|
Total
n=4561 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
471 Participants
n=93 Participants
|
907 Participants
n=4 Participants
|
1378.0 Participants
n=27 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
905 Participants
n=93 Participants
|
1810 Participants
n=4 Participants
|
2715.0 Participants
n=27 Participants
|
|
Age, Categorical
>=65 years
|
199 Participants
n=93 Participants
|
269 Participants
n=4 Participants
|
468.0 Participants
n=27 Participants
|
|
Age Continuous
|
36.96 years
STANDARD_DEVIATION 22.76 • n=93 Participants
|
34.97 years
STANDARD_DEVIATION 21.61 • n=4 Participants
|
35.66 years
STANDARD_DEVIATION 22.03 • n=27 Participants
|
|
Sex: Female, Male
Female
|
892 Participants
n=93 Participants
|
1665 Participants
n=4 Participants
|
2557.0 Participants
n=27 Participants
|
|
Sex: Female, Male
Male
|
683 Participants
n=93 Participants
|
1321 Participants
n=4 Participants
|
2004.0 Participants
n=27 Participants
|
|
Region of Enrollment
Canada
|
1575 participants
n=93 Participants
|
2986 participants
n=4 Participants
|
4561.0 participants
n=27 Participants
|
PRIMARY outcome
Timeframe: 8 yearsOutcome measures
| Measure |
Unexposed to Gastroenteritis
n=829 Participants
|
Exposed to Gastroenteritis
n=1586 Participants
|
|---|---|---|
|
Number of Participants With Post Infectious Irritable Bowel Syndrome
|
23 participants
|
114 participants
|
Adverse Events
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: LTE60